A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. [electronic resource]
Producer: 19910828Description: 832-7 p. digitalISSN:- 0013-7227
- Animals
- Breast Neoplasms -- drug therapy
- Calcitriol -- analogs & derivatives
- Calcium -- blood
- Cell Differentiation -- drug effects
- Cell Division -- drug effects
- Doxorubicin -- therapeutic use
- Humans
- Hypercalcemia -- chemically induced
- Kinetics
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Receptors, Estrogen -- analysis
- Serum Albumin -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.